Researchers identified 5-androstene-3β,17β-diol (ADIOL), a steroid hormone discovered nearly 100 years ago, as the molecular bridge connecting fasting and caloric restriction to improved healthspan. In C. elegans worms, dietary restriction activates ADIOL production, which then binds to NHR-91 (the worm equivalent of estrogen receptor β) to reduce kynurenic acid levels in neural tissue, enhancing health during aging. This discovery illuminates why fasting protocols improve cognitive function and neurological health across species. The kynurenine pathway, which ADIOL modulates, is already recognized as crucial for neuroprotection in mammals, suggesting this mechanism likely operates in humans. Particularly intriguing is that ADIOL supplementation worked even in aged worms, indicating therapeutic potential for older adults. However, ADIOL specifically improved healthspan without extending maximum lifespan, distinguishing it from classic longevity interventions. This research provides the first clear mechanistic explanation for fasting's neural benefits and positions ADIOL as a potential therapeutic target. The evolutionary conservation from worms to mammals strongly suggests this pathway represents a fundamental biological mechanism linking metabolic state to brain health.